{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:08:39Z","timestamp":1740107319413,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-023-04526-2","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T13:51:47Z","timestamp":1694699507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multimodal assessment after total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer accurately predicts complete responders"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-6811","authenticated-orcid":false,"given":"Emre","family":"\u00d6zoran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim Halil","family":"\u00d6zata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya Salim","family":"Uymaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nail","family":"Omarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tutku","family":"T\u00fcfek\u00e7i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih Nafiz","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"G\u00fcrb\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Sel\u00e7ukbiricik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"B\u00f6l\u00fckba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhun \u00c7\u0131\u011f","family":"Ta\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengi","family":"G\u00fcrses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Renc\u00fczo\u011fullar\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dursun","family":"Bu\u011fra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Bal\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"4526_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-3-030-01165-9_28","volume-title":"The ASCRS manual of colon and rectal surgery","author":"A Cercek","year":"2019","unstructured":"Cercek A, Garcia-Aguilar J (2019) Rectal cancer: neoadjuvant therapy. In: Steele SR, Hull TL, Hyman N, Maykel JA, Read TE, Whitlow CB (eds) The ASCRS manual of colon and rectal surgery. Springer International Publishing, Cham, pp 385\u2013395"},{"key":"4526_CR2","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731\u20131740","journal-title":"N Engl J Med"},{"issue":"11","key":"4526_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11):1114\u20131123","journal-title":"N Engl J Med"},{"issue":"14","key":"4526_CR4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJM199704033361402","volume":"336","author":"B Cedermark","year":"1997","unstructured":"Cedermark B, Dahlberg M, Glimelius B, P\u00e5hlman L, Rutqvist LE, Wilking N (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336(14):980\u2013987","journal-title":"N Engl J Med"},{"issue":"5","key":"4526_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"KC Peeters","year":"2007","unstructured":"Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693\u2013701","journal-title":"Ann Surg"},{"issue":"2","key":"4526_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","volume":"15","author":"JF Bosset","year":"2014","unstructured":"Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ et al (2014) Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 15(2):184\u2013190","journal-title":"Lancet Oncol"},{"issue":"2","key":"4526_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2014.10.006","volume":"113","author":"A Sainato","year":"2014","unstructured":"Sainato A, Cernusco Luna Nunzia V, Valentini V, De Paoli A, Maurizi ER, Lupattelli M et al (2014) No benefit of adjuvant fluorouracil leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT). Radiother Oncol 113(2):223\u2013229","journal-title":"Radiother Oncol"},{"issue":"6","key":"4526_CR8","doi-asserted-by":"publisher","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","volume":"4","author":"A Cercek","year":"2018","unstructured":"Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, Guillem JG, Paty PB, Yaeger R, Stadler ZK, Seier K, Gonen M, Segal NH, Reidy DL, Varghese A, Shia J, Vakiani E, Wu AJ, Crane CH, Gollub MJ, Garcia-Aguilar J, Saltz LB, Weiser MR (2018) Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol 4(6):e180071","journal-title":"JAMA Oncol"},{"issue":"23","key":"4526_CR9","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Paty PB, Weiser MR, Nash GM, Pappou E, Guillem JG, Temple L, Wei IH, Widmar M, Lin S, Segal NH, Cercek A, Yaeger R, Smith JJ, Goodman KA, Wu AJ, Saltz LB (2022) Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 40(23):2546\u20132556","journal-title":"J Clin Oncol"},{"issue":"8","key":"4526_CR10","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/annonc\/mdv223","volume":"26","author":"C Fernandez-Martos","year":"2015","unstructured":"Fernandez-Martos C, Garcia-Albeniz X, Pericay C, Maurel J, Aparicio J, Montagut C, Safont MJ, Salud A, Vera R, Massuti B, Escudero P, Alonso V, Bosch C, Martin M, Minsky BD (2015) Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial\u2020. Ann Oncol 26(8):1722\u20131728","journal-title":"Ann Oncol"},{"issue":"4","key":"4526_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","volume":"240","author":"A Habr-Gama","year":"2004","unstructured":"Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4):711\u2013717; discussion 7\u20138","journal-title":"Ann Surg"},{"issue":"12","key":"4526_CR12","doi-asserted-by":"publisher","first-page":"djw171","DOI":"10.1093\/jnci\/djw171","volume":"108","author":"MH Martens","year":"2016","unstructured":"Martens MH, Maas M, Heijnen LA, Lambregts DM, Leijtens JW, Stassen LP, Breukink SO, Hoff C, Belgers EJ, Melenhorst J, Jansen R, Buijsen J, Hoofwijk TG, Beets-Tan RG, Beets GL (2016) Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst 108(12):djw171","journal-title":"J Natl Cancer Inst"},{"issue":"35","key":"4526_CR13","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","volume":"29","author":"M Maas","year":"2011","unstructured":"Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, van Dam RM, Jansen RL, Sosef M, Leijtens JW, Hulsew\u00e9 KW, Buijsen J, Beets GL (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29(35):4633\u20134640","journal-title":"J Clin Oncol"},{"issue":"23","key":"4526_CR14","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J et al (2022) Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 40(23):2546\u20132556. https:\/\/doi.org\/10.1200\/JCO.22.00032","journal-title":"J Clin Oncol"},{"issue":"1","key":"4526_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clcc.2021.11.002","volume":"21","author":"S Mendis","year":"2022","unstructured":"Mendis S, To YH, Tie J (2022) Biomarkers in locally advanced rectal cancer: a review. Clin Colorectal Cancer 21(1):36\u201344","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"4526_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ejca.2013.12.007","volume":"50","author":"SK Yu","year":"2014","unstructured":"Yu SK, Chand M, Tait DM, Brown G (2014) Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. Eur J Cancer 50(5):920\u2013927. https:\/\/doi.org\/10.1016\/j.ejca.2013.12.007","journal-title":"Eur J Cancer"},{"issue":"1","key":"4526_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/DCR.0000000000000266","volume":"58","author":"AG Mace","year":"2015","unstructured":"Mace AG, Pai RK, Stocchi L, Kalady MF (2015) American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer. Dis Colon Rectum 58(1):32\u201344. https:\/\/doi.org\/10.1097\/DCR.0000000000000266","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"4526_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF01645318","volume":"3","author":"P Quirke","year":"1988","unstructured":"Quirke P, Dixon MF (1988) The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 3(2):127\u2013131. https:\/\/doi.org\/10.1007\/BF01645318. PMID: 3045231","journal-title":"Int J Colorectal Dis"},{"issue":"20","key":"4526_CR19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"4526_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jmri.22076","volume":"31","author":"J-Y Choi","year":"2010","unstructured":"Choi J-Y, Choi J-S, Kim M-J, Lim JS, Park MS, Kim JH, Chung YE (2010) Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent. J Magn Reson Imaging 31:571\u2013578. https:\/\/doi.org\/10.1002\/jmri.22076","journal-title":"J Magn Reson Imaging"},{"key":"4526_CR21","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1245\/s10434-011-1776-2","volume":"18","author":"OC Shihab","year":"2011","unstructured":"Shihab OC, Taylor F, Salerno G, Heald RJ, Quirke P, Moran BJ, Brown G (2011) MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 18:3278\u20133284","journal-title":"Ann Surg Oncol"},{"key":"4526_CR22","doi-asserted-by":"publisher","unstructured":"Fernandes MC, Gollub MJ, Brown G (2022) The importance of MRI for rectal cancer evaluation. Surg Oncol 43:101739, ISSN 0960\u20137404. https:\/\/doi.org\/10.1016\/j.suronc.2022.101739","DOI":"10.1016\/j.suronc.2022.101739"},{"key":"4526_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13244-021-01055-w","volume":"12","author":"I Santiago","year":"2021","unstructured":"Santiago I, Rodrigues B, Barata M et al (2021) Re-staging and follow-up of rectal cancer patients with MR imaging when \u201cwatch-and-wait\u201d is an option: a practical guide. Insights Imaging 12:114. https:\/\/doi.org\/10.1186\/s13244-021-01055-w","journal-title":"Insights Imaging"},{"issue":"5","key":"4526_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0037-1606117.)","volume":"30","author":"PB Lynn","year":"2017","unstructured":"Lynn PB, Strombom P, Garcia-Aguilar J (2017) Organ-preserving strategies for the management of near-complete responses in rectal cancer after neoadjuvant chemoradiation. Clin Colon Rectal Surg 30(5):395\u2013403. https:\/\/doi.org\/10.1055\/s-0037-1606117.)","journal-title":"Clin Colon Rectal Surg"},{"key":"4526_CR25","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/DCR.0b013e3181f42b89","volume":"53","author":"A Habr-Gama","year":"2010","unstructured":"Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama RJ (2010) Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 53:1692\u20131698","journal-title":"Dis Colon Rectum"},{"key":"4526_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1245\/s10434-011-1933-7","volume":"19","author":"J Garcia-Aguilar","year":"2012","unstructured":"Garcia-Aguilar J, Shi Q, Thomas CR Jr et al (2012) A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol 19:384\u2013391","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"4526_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM et al (2022) Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20(10):1139\u20131167. https:\/\/doi.org\/10.6004\/jnccn.2022.0051","journal-title":"J Natl Compr Canc Netw"},{"issue":"23","key":"4526_CR28","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343\u20132351","journal-title":"N Engl J Med"},{"issue":"4","key":"4526_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.bjc.6600467","volume":"87","author":"SL Cheeseman","year":"2002","unstructured":"Cheeseman SL, Joel SP, Chester JD, Wilson G, Dent JT, Richards FJ et al (2002) A \u2018modified de Gramont\u2019 regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. Br J Cancer 87(4):393\u2013399","journal-title":"Br J Cancer"},{"issue":"11","key":"4526_CR30","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1023\/A:1026520812351","volume":"11","author":"F Maindrault-Goebel","year":"2000","unstructured":"Maindrault-Goebel F, de Gramont A, Louvet C, Andr\u00e9 T, Carola E, Gilles V, Oncology Multidisciplinary Research Group (GERCOR) et al (2000) Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Ann Oncol 11(11):1477\u20131483","journal-title":"Ann Oncol"},{"issue":"1","key":"4526_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1200\/JCO.2006.08.1075","volume":"25","author":"HJ Schmoll","year":"2007","unstructured":"Schmoll HJ, Cartwright T, Tabernero J, Nowacki MP, Figer A, Maroun J et al (2007) Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J Clin Oncol 25(1):102\u2013109","journal-title":"J Clin Oncol"},{"issue":"11","key":"4526_CR32","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","volume":"29","author":"DG Haller","year":"2011","unstructured":"Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E et al (2011) Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 29(11):1465\u20131471","journal-title":"J Clin Oncol"},{"issue":"10139","key":"4526_CR33","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH, IWWD Consortium (2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 391(10139):2537\u20132545","journal-title":"Lancet"},{"issue":"6","key":"4526_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/SLA.0000000000002761","volume":"268","author":"M Dattani","year":"2018","unstructured":"Dattani M, Heald RJ, Goussous G, Broadhurst J, S\u00e3o Juli\u00e3o GP, Habr-Gama A, Perez RO, Moran BJ (2018) Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg 268(6):955\u2013967","journal-title":"Ann Surg"},{"issue":"12","key":"4526_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S2468-1253(18)30301-7","volume":"3","author":"SA Chadi","year":"2018","unstructured":"Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Sun Myint A, Smith FM, Saunders MP, Scott N, O\u2019Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Sao Juliao G, Perez R, Renehan AG (2018) Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol 3(12):825\u2013836","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"4526_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/DCR.0000000000002197","volume":"65","author":"GC Cotti","year":"2022","unstructured":"Cotti GC, Pandini RV, Braghiroli OFM, Nahas CSR, Bustamante-Lopez LA, Marques CFS, Imperiale AR, Ribeiro U Jr, Salvajoli B, Hoff PM, Nahas SC (2022) Outcomes of patients with local regrowth after nonoperative management of rectal cancer after neoadjuvant chemoradiotherapy. Dis Colon Rectum 65(3):333\u2013339","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"4526_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1470-2045(20)30557-X","volume":"22","author":"LM Fernandez","year":"2021","unstructured":"Fernandez LM, S\u00e3o Juli\u00e3o GP, Figueiredo NL, Beets GL, van der Valk MJM, Bahadoer RR, Hilling DE, Meershoek-Klein Kranenbarg E, Roodvoets AGH, Renehan AG, van de Velde CJH, Habr-Gama A, Perez RO, International Watch & Wait Database Consortium (2021) Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol 22(1):43\u201350","journal-title":"Lancet Oncol"},{"key":"4526_CR38","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1007\/s00261-019-02019-x","volume":"44","author":"N Horvat","year":"2019","unstructured":"Horvat N, Hope TA, Pickhardt PJ et al (2019) Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol 44:3569\u20133580. https:\/\/doi.org\/10.1007\/s00261-019-02019-x","journal-title":"Abdom Radiol"},{"issue":"9","key":"4526_CR39","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1111\/codi.15760","volume":"23","author":"T Ko\u00ebter","year":"2021","unstructured":"Ko\u00ebter T, Stijns RCH, van Koeverden S, Hugen N, van der Heijden JAG, Nederend J, van Zwam PH, Nagtegaal ID, Verheij M, Rutten HJT, de Wilt JHW (2021) Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy. Colorectal Dis 23(9):2341\u20132347. https:\/\/doi.org\/10.1111\/codi.15760. Epub 2021 Jun 22. PMID: 34051043; PMCID: PMC8519080","journal-title":"Colorectal Dis"},{"issue":"2","key":"4526_CR40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0000000000004499","volume":"276","author":"AC Lord","year":"2022","unstructured":"Lord AC, D\u2019Souza N, Shaw A, Rokan Z, Moran B, Abulafi M, Rasheed S, Chandramohan A, Corr A, Chau I, Brown G (2022) MRI-diagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Ann Surg 276(2):334\u2013344","journal-title":"Ann Surg"},{"issue":"3","key":"4526_CR41","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1245\/s10434-021-11121-8","volume":"29","author":"F Marchegiani","year":"2022","unstructured":"Marchegiani F, Palatucci V, Capelli G, Guerrieri M, Belluco C, Rega D, Morpurgo E, Coco C, Restivo A, De Franciscis S, Aschele C, Perin A, Bonomo M, Muratore A, Spinelli A, Ramuscello S, Bergamo F, Montesi G, Spolverato G, Del Bianco P, Gambacorta MA, Delrio P, Pucciarelli S (2022) Rectal sparing approach after neoadjuvant therapy in patients with rectal cancer: the preliminary results of the ReSARCh trial. Ann Surg Oncol 29(3):1880\u20131889","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4526_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jmri.22613","volume":"34","author":"A Muhi","year":"2011","unstructured":"Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34(2):326\u2013335. https:\/\/doi.org\/10.1002\/jmri.22613. PMID: 21780227","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"4526_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP, RAPIDO collaborative investigators (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1):29\u201342","journal-title":"Lancet Oncol"},{"issue":"8","key":"4526_CR44","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","volume":"16","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR, Stamos MJ, Ternent CA, Herzig DO, Fichera A, Polite BN, Dietz DW, Patil S, Avila K, Timing of Rectal Cancer Response to Chemoradiation Consortium (2015) Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 16(8):957\u2013966","journal-title":"Lancet Oncol"},{"issue":"10","key":"4526_CR45","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/DCR.0000000000001207","volume":"61","author":"MR Marco","year":"2018","unstructured":"Marco MR, Zhou L, Patil S, Marcet JE, Varma MG, Oommen S, Cataldo PA, Hunt SR, Kumar A, Herzig DO, Fichera A, Polite BN, Hyman NH, Ternent CA, Stamos MJ, Pigazzi A, Dietz D, Yakunina Y, Pelossof R, Garcia-Aguilar J, Timing of Rectal Cancer Response to Chemoradiation Consortium (2018) Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: final results of a multicenter phase II trial. Dis Colon Rectum 61(10):1146\u20131155","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"4526_CR46","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ijrobp.2012.01.096","volume":"84","author":"RO Perez","year":"2012","unstructured":"Perez RO, Habr-Gama A, S\u00e3o Juli\u00e3o GP, Gama-Rodrigues J, Sousa AH Jr, Campos FG et al (2012) Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys 84(5):1159\u20131165","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"4526_CR47","doi-asserted-by":"publisher","first-page":"e2030097","DOI":"10.1001\/jamanetworkopen.2020.30097","volume":"3","author":"A Kasi","year":"2020","unstructured":"Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J et al (2020) Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw Open 3(12):e2030097","journal-title":"JAMA Netw Open"},{"issue":"7","key":"4526_CR48","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/bjs.8702","volume":"99","author":"ST Martin","year":"2012","unstructured":"Martin ST, Heneghan HM, Winter DC (2012) Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 99(7):918\u2013928","journal-title":"Br J Surg"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04526-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-023-04526-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04526-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T11:34:23Z","timestamp":1703158463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-023-04526-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4526"],"URL":"https:\/\/doi.org\/10.1007\/s00384-023-04526-2","relation":{},"ISSN":["1432-1262"],"issn-type":[{"type":"electronic","value":"1432-1262"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"8 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ko\u00e7 University Ethics Committee with the Approval No. 2021.193.IRB1.066.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"229"}}